Raj S. Pruthi

Raj S. Pruthi currently serves as the Chief Medical Officer for Urology at Relmada Therapeutics, Inc., and holds a professorship at the Department of Health System Sciences at Thomas F. Frist, Jr. College of Medicine at Belmont University. Additionally, Raj Pruthi is an Adjunct Professor in the Department of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Previous roles include Chief Medical Officer at enGene and Acting Global Medical Affairs Lead for the TAR-210 Bladder Cancer Program at The Janssen Pharmaceutical Companies of Johnson & Johnson. Academic positions have been held at the University of California, San Francisco, and the University of North Carolina at Chapel Hill, where Raj Pruthi was Chair of the Department of Urology and contributed significantly to urologic oncology. Educational credentials include a Doctor of Medicine degree from Duke University School of Medicine, along with multiple degrees from Stanford University, including a Bachelor of Arts in Economics with Honors and a Bachelor of Science in Biology. Raj Pruthi also obtained a Master of Health Administration from the University of North Carolina at Chapel Hill.